Literature DB >> 2328546

Differences in organization of metastatic and nonmetastatic tumors initiated by the same B16 melanoma clone in mature and young mice.

C W Stackpole1, A L Alterman, C V Angadi, Y S Kim, D M Fornabaio.   

Abstract

Subcutaneous transplants of mouse B16 melanoma clone G3.26 grow more slowly, and are markedly more metastatic to the lungs, in mature (greater than 12-month-old) mice than in young (2-month-old) mice. Previous studies suggested that tumors in young mice fail to disseminate viable tumor cells into the hematogenous circulation. To determine if changes in intratumor organization might accompany this altered tumor behavior, G3.26 tumors growing in young and mature mice were examined comparatively at progressive sizes relative to the onset of metastatic dissemination in the older mice. Although the degree of necrosis was comparable in both groups of tumors, vascular density, measured morphometrically in histological sections, was significantly lower in tumors from mature mice at a size when dissemination would be occurring. With the onset of reduced vascular density in tumors in mature mice, there was a substantial increase in the proportion of viable tumor cells that was hypoxic, based on radioresistance and incorporation of the hypoxic cell sensitizer, misonidazole. Quiescent tumor cells, identified by flow cytometry, were also more numerous in tumors from mature mice than in tumors from young mice. Although the importance of these differences in tumor organization to enhanced metastatic behavior is unclear, increased intratumor hypoxia might promote generation of metastatic variants. Alternately, dissemination of tumor cells might be facilitated through a reduced and possibly defective vasculature.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2328546     DOI: 10.1007/bf00141256

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  30 in total

1.  Modifications of a specific assay for hydroxyproline in urine.

Authors:  K I Kivirikko; O Laitinen; D J Prockop
Journal:  Anal Biochem       Date:  1967-05       Impact factor: 3.365

2.  Macrophages and metastasis--a biological approach to cancer therapy.

Authors:  I J Fidler
Journal:  Cancer Res       Date:  1985-10       Impact factor: 12.701

3.  Tumor vasculature in young and old hosts: scanning electron microscopy of microcorrosion casts with microangiography, light microscopy and transmission electron microscopy.

Authors:  J G Walmsley; S R Granter; M P Hacker; A L Moore; W B Ershler
Journal:  Scanning Microsc       Date:  1987-06

4.  Development of host immunity to phenotypically diverse B16 melanoma clones. Implications for tumor growth and metastasis.

Authors:  C W Stackpole; A L Alterman; S Braverman; I Rappaport
Journal:  Invasion Metastasis       Date:  1987

5.  Increased invasion and spontaneous metastasis of BL6 melanoma with inhibition of the desmoplastic response in C57 BL/6 mice.

Authors:  S H Barsky; R Gopalakrishna
Journal:  Cancer Res       Date:  1987-03-15       Impact factor: 12.701

6.  Effect of radiation-induced injury of tumor bed stroma on metastatic spread of murine sarcomas and carcinomas.

Authors:  L Milas; H Hirata; N Hunter; L J Peters
Journal:  Cancer Res       Date:  1988-04-15       Impact factor: 12.701

7.  Basement membrane collagen: degradation by migrating endothelial cells.

Authors:  T Kalebic; S Garbisa; B Glaser; L A Liotta
Journal:  Science       Date:  1983-07-15       Impact factor: 47.728

Review 8.  Biological properties of ICRF-159 and related bis(dioxopiperazine) compounds.

Authors:  E H Herman; D T Witiak; K Hellmann; V S Waravdekar
Journal:  Adv Pharmacol Chemother       Date:  1982

9.  Hypoxic fractions of solid tumors: experimental techniques, methods of analysis, and a survey of existing data.

Authors:  J E Moulder; S Rockwell
Journal:  Int J Radiat Oncol Biol Phys       Date:  1984-05       Impact factor: 7.038

10.  Lymphocyte-induced angiogenesis factor is produced by L3T4+ murine T lymphocytes, and its production declines with age.

Authors:  E J Hadar; W B Ershler; R A Kreisle; S P Ho; M J Volk; R G Klopp
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.